Impact of Magnetic Resonance and Biomarkers for Screening for Prostate Cancer. Cost-effectiveness Analysis
Conditions
- Establish the Efficacy Between the Four Schemes in Terms of the Aggressiveness of the Tumors According to the Gleason Classification
- Establish the Efficacy Between the Four Schemes in Terms of Morbidity Associated With the Technique
- Establish the Efficacy Between the Four Schemes in Terms of the Patient's Subjective Perception Regarding Pain and Quality of Life
- Establish the Association of the Tumor Biomarker in the Early Detection and Aggressiveness of Tumors
- Establish the Possible Interaction Between Biomarkers and Resonance in Different Prostate Biopsy Models to Define Tumor Presence and / or Tumor Aggressiveness
- Establish the Possible Relationship Between the Expression Profiles of the microRNAs
- Establish if There Are Differences Between Transrectal and Transperineal Prostatic Biopsy Schemes in Both Cases With and Without MRI
Interventions
- PROCEDURE: Multiparametric magnetic resonance
Sponsor
InvestigatorUrologyIBSAL
Collaborators